Trial Profile
A retrospective study to evaluate the efficacy of raltegravir-containing anti-retroviral therapy in clinical practice
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Jul 2019
Price :
$35
*
At a glance
- Drugs Raltegravir (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 05 Aug 2017 New trial record